c.balogun

TL2 · Kochi

Contributes reviews on supplier material. Based in Kochi.

Joined 6 August 2025 · last posted 12d

74 posts, newest first. Showing up to 150.

How shortages have affected compounding permissions Replied, post #43 · Access › Shortages · 16 Jul 2026 · 30 likes Where I part company with post #39, and it is a narrow parting. Filing a mild objection to the consensus on shortages. Mild because I might be wrong; an objection…
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #74 · Analytics › Home & field testing · 11 Jul 2026 · 18 likes Post #70 and I disagree about the size of the effect, not about the direction. The honest cost comparison is a home kit against a single independent submission. For…
Carryover and the ghost peak from last week's standard — what changed since Replied, post #85 · Analytics › HPLC & UHPLC · 29 Jun 2026 · 32 likes Reversed-phase separates on hydrophobicity. A peptide is retained on a non-polar stationary phase and eluted by increasing organic solvent. For peptides the mobile…
GHRH analogues versus ghrelin mimetics: different mechanisms, conflated discussion Replied, post #32 · Compounds › Secretagogues & GH axis · 28 Jun 2026 · 0 likes This follows post #29 rather than contradicting it. Marking my uncertainty on GHRH analogues versus ghrelin mimetics explicitly. I am confident about the direction,…
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #114 · Practice › Reconstitution · 17 Jun 2026 · 14 likes On post #111 — agreed on the reasoning, with one qualification. Reconstituting a multi-strength kit: if a kit contains 5 mg, 10 mg, 15 mg vials and you are…
Secretagogues and glucose tolerance: the mechanistic concern Replied, post #37 · Compounds › Secretagogues & GH axis · 16 Jun 2026 · 12 likes No notes. Posting so the count is not one.
Trust level 3 requirements: a clarification — does this still hold? Replied, post #61 · Meta › Announcements · 9 Jun 2026 · 2 likes The reason Trust level 3 requirements is hard to answer is that the obvious measurement and the relevant quantity are not the same thing, and substituting one for the…
Does dual agonism explain the effect size, or is it dose? Replied, post #14 · Compounds › Tirzepatide · 3 Jun 2026 · 12 likes I changed my mind about dual agonism after someone here asked me for the source and I could not produce one. That is worth saying out loud because it is the ordinary…
The arithmetic of an intermediate dose between two label steps Replied, post #3 · Practice › Dosing & titration · 23 May 2026 · 0 likes Acknowledging rather than arguing. The reasoning holds as far as I can follow it.
Packaging that arrived damaged: documenting it properly Replied, post #13 · Sourcing › Logistics · 22 May 2026 · 18 likes Right, and stated more narrowly than I would have dared to state it.
Revisiting: Liver enzymes drifting down and what that usually means Replied, post #34 · Clinical › Bloodwork · 19 May 2026 · 0 likes Where a panel includes a calculated value, that value inherits the imprecision of everything it was calculated from and is usually reported without an interval.
Follow-up: A parcel that arrived warm: a decision process, not a verdict Replied, post #19 · Practice › Storage & stability · 8 May 2026 · 1 like I had written a reply contradicting post #17 and deleted it. Here is what survived. Clarity is a weak test. A solution can lose a significant fraction of its active…
Coming back to: Measurement error in a self-reported exposure Replied, post #26 · Evidence › Study critique · 28 Apr 2026 · 32 likes Picking up post #23: that is the part I would want checked first. Criticism is more useful when it is narrower. "The trial answers a different question from the one…
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #4 · Compounds › Tirzepatide · 27 Apr 2026 · 18 likes Categorical response thresholds — the proportion reaching ten, fifteen or twenty per cent reduction — are more persuasive and less informative than the mean. They…
[2026 update] Are there stupid questions here? A staff answer, at length Replied, post #31 · Start Here › Welcome · 21 Apr 2026 · 10 likes Welcome. The orientation materials are pinned at the top of this category and they take about an hour. They answer most of the questions a new member has and they save…
Why the absence of controlled human data on BPC-157 matters more than people admit Replied, post #11 · Compounds › Repair & healing peptides · 13 Apr 2026 · 0 likes Reading back through the absence of controlled human data threads from last year, the same three questions come up every time and only one of them has ever been…
Grapefruit: why this class is not the class that cares Replied, post #51 · Practice › Interactions · 18 Mar 2026 · 17 likes Understood. Thank you for being specific about the limits of it.
Research-use-only status: what it means legally and practically Replied, post #14 · Compounds › Other compounds · 14 Mar 2026 · 0 likes On post #12 — agreed on the reasoning, with one qualification. Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which…
A payment that went through twice: how it was resolved Replied, post #20 · Sourcing › Payments · 10 Mar 2026 · 13 likes A first order deliberately smaller than you need is the standard risk-limiting approach here and it costs a little more per unit for a reason. Not disagreeing with…
Introducing myself: pharmacist, sceptic, reluctant participant — one year on Replied, post #15 · Lounge › Introductions · 8 Mar 2026 · 16 likes Welcome. The short version of the culture: be specific, date everything, and say when you are guessing. That is genuinely the whole of it. That is where I would start,…
Documenting a payment dispute without naming and shaming Replied, post #4 · Sourcing › Payments · 4 Mar 2026 · 2 likes Confirming post #3 from a second method, which matters more than confirming it from a second person. Cryptocurrency for payment: offers less fraud protection than…
Waist circumference technique and its repeatability Replied, post #56 · Outcomes › Progress reports · 25 Feb 2026 · 3 likes Following, with nothing to contribute beyond having asked the same thing elsewhere.
Seven-day rolling means and why weekly readings mislead — one year on Replied, post #41 · Outcomes › Progress reports · 12 Feb 2026 · 4 likes The arithmetic in post #39 is right; the assumption feeding it is the part to check. Filing a mild objection to the consensus on Seven-day rolling. Mild because I might…
Ultrasound and skinfolds: operator dependence in practice — what changed since Replied, post #13 · Outcomes › Body composition · 4 Feb 2026 · 0 likes The question underneath Ultrasound and skinfolds is usually "how would I tell?" rather than "what is true?", and that one has a method attached to it. Write down what…
Amylin receptor signalling and satiety — what changed since Replied, post #17 · Pharmacology › Receptor biology · 17 Jan 2026 · 0 likes Signalling through cyclic AMP is the canonical pathway and is not the only one. Beta-arrestin recruitment differs between ligands and its clinical significance here is…
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #54 · Access › Pricing · 5 Jan 2026 · 7 likes List prices versus negotiated prices: the price a pharmaceutical company publishes and the price an insurance company or pharmacy actually pays differ substantially.…
Pharmacy supply in the UK and the questions you will be asked Replied, post #2 · Regional › UK & Ireland · 3 Jan 2026 · 5 likes Pharmacy supply has been discussed here with more heat than it deserves, mostly because two definitions have been in play the whole time.
Coming back to: A newcomer's list of things that confused me, and the fixes Started this topic · Start Here › Welcome · 30 Dec 2025 · 0 likes Posting this under the heading it deserves: A newcomer's list of things that confused me, and the fixes Everything below is what sits behind that. Question in the…
Distinguishing expected GI effects from something that needs urgent attention Replied, post #2 · Practice › Side effects · 30 Dec 2025 · 18 likes The relationship between symptom burden and outcome is not what people assume. Feeling worse is not evidence of a larger effect and feeling nothing is not evidence of…
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #71 · Compounds › Semaglutide · 17 Dec 2025 · 0 likes I have no financial interest in anything named in this thread and I want to say so before I comment on semaglutide half-life, because it is the sort of subject where it…
Pinch or no pinch, and how needle length changes the answer — the long version Started this topic · Practice › Administration · 13 Dec 2025 · 3 likes On the subject in the title: Pinch or no pinch, and how needle length changes the answer — the long version Working notes rather than a conclusion. A narrow question…
Follow-up: A supplier that answers analytical questions with restated claims Replied, post #5 · Sourcing › Red flags · 2 Dec 2025 · 1 like Counterpoint on supplier, offered without confidence: the same observation is consistent with a much duller explanation, and nobody has ruled the dull one out.
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly — the long… Replied, post #13 · Compounds › Tirzepatide · 1 Dec 2025 · 15 likes The GIP component: GIP receptor agonism is thought to amplify the GLP-1 effect on satiety and energy expenditure, but how much of tirzepatide's effect is that and how…
Oral semaglutide bioavailability and its variability between people Replied, post #18 · Compounds › Oral incretins · 30 Nov 2025 · 0 likes Taking the oral product with more water than instructed reduces absorption rather than helping it. That is counter-intuitive and it is one of the few dosing…
Thyroid function tests during substantial weight change Replied, post #138 · Clinical › Bloodwork · 17 Nov 2025 · 2 likes Answering the question post #136 raises rather than the one it answers. A trend needs at least three points to be a trend. Two points are a line and a line through…
Meeting a protein target on a suppressed appetite Replied, post #32 · Nutrition & Training › Protein & intake · 1 Nov 2025 · 0 likes Protein sources: animal sources (meat, fish, eggs, dairy) are denser and easier to hit targets with. Plant sources require higher volume. Neither is nutritionally…
Airline travel with a temperature-sensitive injectable — what changed since Replied, post #88 · Devices › Cold chain · 10 Oct 2025 · 26 likes Insulation performance depends on the mass of the coolant more than on the thickness of the box. A large pack in a modest box outperforms a small pack in a good one.
Insurance and replacement policies, compared — the long version Replied, post #16 · Sourcing › Logistics · 16 Sep 2025 · 13 likes Worth separating two things that post #14 runs together. On Insurance and replacement policies the community has more anecdote than the confidence in this thread…
What a purity-only report leaves out Replied, post #11 · Sourcing › Independent verification · 11 Sep 2025 · 1 like Worth separating purity-only as a question about the compound from purity-only as a question about the documentation. They get answered by different people and only one…
Aggregated purity results across four services, with caveats — a second dataset Replied, post #87 · Data & Tools › Datasets · 9 Sep 2025 · 24 likes If you are new and reading this thread for the answer to Aggregated purity results across four: the answer is conditional, the conditions are in the third reply, and…
Aggregated purity results across four services, with caveats — a second dataset Replied, post #64 · Data & Tools › Datasets · 8 Sep 2025 · 6 likes A dataset is only useful if the collection method is described alongside it. Numbers without a protocol are a list rather than data. Same conclusion as the reply above,…
Specificity, linearity, accuracy, precision, range, robustness — with real criteria — a… Replied, post #24 · Analytics › Method validation · 8 Sep 2025 · 26 likes On post #22 — agreed on the reasoning, with one qualification. Accuracy: the method measures what you intend to measure. For purity methods, this is tested by…
Revisiting: Why a compound being unapproved is not the same as being illegal to possess Replied, post #76 · Sourcing › Regulatory · 11 Aug 2025 · 7 likes Post #73 is right about the mechanism and I think understates the practical bit. One more thing on compound being unapproved that took me far too long to see: the two…
"Greater than or equal to 99%" as a specification rather than a result Replied, post #11 · Analytics › COA interpretation · 25 Jul 2025 · 2 likes An itemised related-substances table with retention times says considerably more about the synthesis than a single total. A total tells you how much is not the main…
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #78 · Compounds › Repair & healing peptides · 23 Jul 2025 · 27 likes The pentadecapeptide sequence is short and stable enough to survive conditions that would degrade a larger peptide, which is one of the few things about it that is well…
Pregnancy as an absolute contraindication — the long version Replied, post #3 · Safety › Contraindications · 7 Jun 2025 · 0 likes Severe hepatic impairment: less is known than for kidney disease. Extreme caution or contraindication depending on the specific degree of impairment.
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #90 · Compounds › Tirzepatide · 21 May 2025 · 12 likes That is a cleaner way of putting what I was circling around.
Pregnancy as an absolute contraindication Replied, post #46 · Safety › Contraindications · 18 May 2025 · 17 likes A contraindication in labelling is a specific statement about a specific product and population, and quoting the actual text is more useful than paraphrasing it.
A supplier that answers analytical questions with restated claims Replied, post #78 · Sourcing › Red flags · 17 May 2025 · 0 likes Two claims get bundled together under supplier and they need separating. The descriptive one — this is what was observed — is usually well supported. The causal one —…
Promotion criteria, and the one that stops most nominations — the long version Replied, post #3 · Documentation › Doc review · 17 May 2025 · 0 likes The most useful thing anyone has posted about Promotion criteria in this category was a table of what had been measured and by whom. That is what I would want again.
Follow-up: Documentation that appears only after payment Replied, post #62 · Sourcing › Red flags · 9 May 2025 · 18 likes A stock listing that never changes and a lead time that never varies are both worth noticing. Real operations have variation in them.
Ipamorelin selectivity claims and where they came from Replied, post #35 · Compounds › Secretagogues & GH axis · 6 May 2025 · 0 likes A mass result for a short peptide is more discriminating than for a long one, because a single residue difference is a larger proportion of the total. That makes…
Second pass at: Manufacturer assistance programmes and their eligibility rules Replied, post #15 · Access › Pricing · 18 Mar 2025 · 1 like Fine by me. I had wanted a stronger conclusion and there is not one available.
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #54 · Practice › Reconstitution · 14 Mar 2025 · 16 likes Adding thanks rather than a view. I do not have a view worth the space.
Reading an MS report that only gives you a single number Replied, post #27 · Analytics › Mass spectrometry · 12 Mar 2025 · 30 likes Desalting before analysis: some samples need desalting to remove salts that suppress the peptide signal. Report whether desalting was used, because it can affect the…
Second pass at: Retatrutide mass and identity: what a report should show Started this topic · Compounds › Retatrutide · 6 Mar 2025 · 10 likes Second pass at: Retatrutide mass and identity: what a report should show — setting out what I have, and where I think it stops being reliable. Two things I would like…
Pharmaceutical compounding rules, summarised from primary sources Replied, post #107 · Sourcing › Regulatory · 4 Mar 2025 · 0 likes That is clearer than the version I had in my head. Thank you.
Validating a method you did not develop — does this still hold? Replied, post #57 · Analytics › Method validation · 28 Feb 2025 · 1 like Forced degradation studies: deliberately stress the material with acid, base, oxidant, heat, light to generate degradation products and demonstrate that the method can…
Distinguishing a deletion sequence by mass alone Replied, post #128 · Analytics › Mass spectrometry · 24 Feb 2025 · 13 likes What mass accuracy establishes: the measured mass is consistent with a specific composition. What it does not establish: purity, sequence order, stereochemistry, or the…
Follow-up: What other technical communities get right that we do not Replied, post #24 · Lounge › Off topic · 23 Feb 2025 · 16 likes Agreed, and the corollary is that a place with no visible corrections is not a place with fewer errors.
SURPASS-2 and the comparator dose question that will not go away Replied, post #106 · Compounds › Tirzepatide · 16 Jan 2025 · 22 likes SURMOUNT-4 used a randomised withdrawal design: everyone titrated, then those on maintenance were randomised to continue or placebo. Continuation maintained effect;…
Follow-up: Individual participant data versus aggregate data Replied, post #110 · Evidence › Meta-analyses · 12 Jan 2025 · 0 likes Post #108 put the caveat in the right place and I want to underline it. Study quality and weighting: some meta-analyses weight all studies equally; others weight by…
Recovery when intake is low: what to cut first Replied, post #11 · Nutrition & Training › Resistance training · 9 Jan 2025 · 1 like The arithmetic in post #10 is right; the assumption feeding it is the part to check. The strongest argument against my own position on recovery, stated as well as I can…
The topic list is dense — is that deliberate? Replied, post #73 · Meta › Site feedback · 27 Dec 2024 · 9 likes Post #71 describes the usual case. This is about the unusual one. Topic list was covered in the wiki last year and the page has a review date on it, which is a better…
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #41 · Compounds › Cagrilintide & amylin analogues · 27 Dec 2024 · 23 likes Answering the question post #37 raises rather than the one it answers. Is synergy the right word for the combination data? A phase 2 trial cannot establish whether…
Coming back to: When to suspect the method rather than the sample Replied, post #120 · Analytics › Method validation · 23 Dec 2024 · 28 likes Narrowing post #117, because the general version has more than one answer. Validation is compound-specific and matrix-specific. A method validated for one peptide is a…
Identical chromatograms across two different lots Replied, post #66 · Sourcing › Red flags · 23 Dec 2024 · 10 likes The guidelines draw that line for a practical reason as much as a fair one: reports accumulate into something useful and allegations do not.
[2026 update] Step therapy requirements and how to satisfy them Replied, post #61 · Access › Insurance & coverage · 9 Dec 2024 · 0 likes Keep every document with dates in one place. An appeal months later is assembled from whatever you kept.
Time to steady state after a dose increase Replied, post #130 · Pharmacology › Pharmacokinetics · 6 Nov 2024 · 30 likes Adding thanks rather than a view. I do not have a view worth the space.
High-resolution MS on aggregates and what it can see — one year on Replied, post #57 · Analytics › Mass spectrometry · 21 Aug 2024 · 0 likes Taking post #54 at face value and following it one step further. Deamidation adds approximately one dalton and produces a species that frequently elutes very close to…
Blind submission and why it changes minds Replied, post #32 · Sourcing › Independent verification · 9 Aug 2024 · 0 likes Blind submission is well covered in the tag pages, and the older discussions are better than the recent ones because they were argued out properly. Worth twenty minutes…
Guidelines revision: what changed and why Replied, post #93 · Meta › Announcements · 27 Jul 2024 · 10 likes A request rather than an answer: could whoever has the primary source for guidelines revision post it? I have seen the claim three times this month and each version had…
Guidelines revision: what changed and why Replied, post #78 · Meta › Announcements · 27 Jul 2024 · 4 likes Good question, well framed, and I would like to see it answered properly.
The mass-error checker and its intended scope Replied, post #68 · Data & Tools › Calculators · 22 Jun 2024 · 5 likes I read the earlier replies on mass-error checker twice before writing this, because I had assumed the opposite and wanted to be sure I was disagreeing with what was…